PolarityTE Inc

NASDAQ:PTE  
2.38
-0.48 (-16.78%)
Products

PolarityTE Provides Update On U.S. FDA Investigational New Drug Application For SkinTE

Published: 08/24/2021 12:38 GMT
PolarityTE Inc (PTE) - Polarityte Provides Update on U.S. FDA Investigational New Drug Application for Skinte®.
Polarityte Inc - Study Proposed in Ind Has Been Placed on Clinical Hold.
Polarityte Inc - FDA Has Advised That It Will Issue a Clinical Hold Letter Providing Details on Basis for Hold to Company by September 21, 2021.